肿瘤防治研究2023，Vol.50Issue(12)：1153-1159,7.DOI:10.3971/j.issn.1000-8578.2023.23.0627
泪腺腺样囊性癌临床诊疗中需关注的问题
Clinical Diagnosis and Treatment of Lacrimal Gland Adenoid Cystic Carcinoma
摘要
Abstract
Lacrimal gland adenoid cystic carcinoma(LGACC)is the most common primary malignant epithelial tumor of the lacrimal gland and has the characteristics of high recurrence rate,neurotropic growth,and risk of distant metastasis.The clinical manifestation is mainly a mass in the lacrimal gland area with a poor specificity.The combination of MRI and CT is important in the diagnosis of LGACC,and PET/CT is of great value in determining the nature and metastasis of LGACC.Histopathological examination is the gold standard for diagnosis,and the type of histopathology is significant for predicting the prognosis of patients.At present,the most commonly used treatment for LGACC is surgical resection combined with postoperative local radiotherapy.However,the overall prognosis is poor after active treatment because the pathogenesis of LGACC remains unclear.This article will combine relevant literature and the author's clinical experience to review the epidemiology,clinical manifestations,imaging examination,histopathological changes,treatment,and prognosis of LGACC.Results will contribute to improve the quality of diagnosis and treatment and the prognosis of patients.关键词
泪腺/腺样囊性癌/诊断/治疗/预后Key words
Lacrimal gland/Adenoid cystic carcinoma/Diagnosis/Treatment/Prognosis分类
医药卫生引用本文复制引用
马建民,任婷婷..泪腺腺样囊性癌临床诊疗中需关注的问题[J].肿瘤防治研究,2023,50(12):1153-1159,7.基金项目
Natural Science Foundation of Beijing(No.7222025) （No.7222025）
Beijing Hospitals Authority'Ascent Plan(No.DFL20190201) （No.DFL20190201）
Beijing Science and Technology Rising Star Program-Cross-Cooperation(No.20220484218)北京市自然科学基金(7222025) （No.20220484218）
北京市医院管理中心登峰人才计划(DFL20190201) （DFL20190201）
北京市科技新星计划交叉合作课题(20220484218) （20220484218）
